---
layout: minimal-medicine
title: Mechlorethamine
---

# Mechlorethamine
### Generic Name
Mechlorethamine

### Usage
Mechlorethamine is a type of chemotherapy drug classified as a nitrogen mustard alkylating agent. Its primary use is in the palliative treatment of several cancers, meaning it aims to relieve symptoms and improve quality of life rather than achieving a cure.  These cancers include:

* **Hodgkin's lymphoma (stages III and IV):** This is a type of blood cancer affecting the lymphatic system.
* **Lymphosarcoma:** A cancer of the lymphatic system.
* **Chronic myelocytic leukemia (CML) and chronic lymphocytic leukemia (CLL):** These are cancers affecting the bone marrow's production of white blood cells.
* **Polycythemia vera:** A blood disorder characterized by the overproduction of red blood cells.
* **Mycosis fungoides:** A type of cutaneous T-cell lymphoma (skin cancer).
* **Bronchogenic carcinoma:** Lung cancer.

Topical mechlorethamine is also used to treat stage IA and IB mycosis fungoides in patients who have had other skin treatments.

### Dosage

Dosage of mechlorethamine varies significantly depending on the specific cancer being treated, the route of administration (intravenous, intracavitary, or topical), and the patient's weight and overall health.  It is crucial to follow a physician's precise instructions.  There is no standardized pediatric dosage, as safety and efficacy haven't been established in children.

**Adult Dosage (Examples – Always follow physician's orders):**

* **Intravenous (IV):**  Dosage ranges widely, from 0.1-0.2 mg/kg/day in divided doses, to 0.4 mg/kg per course as a single dose,  or following specific regimens like MOPP (for Hodgkin's lymphoma) at 6 mg/m² on days 1 and 8 of a 28-day cycle.  The MOPP regimen and others often involve combinations of medications.

* **Intracavitary (into body cavities):** Used for treating malignant effusions (cancerous fluid buildup).  Dosage typically ranges from 0.2 to 0.4 mg/kg as a single dose, depending on the location (e.g., intrapericardial).

* **Topical:** For mycosis fungoides, a thin film of a 0.1 mg/mL solution is applied once daily to affected skin areas, limited to areas no larger than 3x5 cm.


**Dosage Adjustments:**

* **Hepatic Impairment:**  Mild to moderate impairment usually doesn't require dosage adjustment. Severe impairment may necessitate changes to concurrent chemotherapy but not necessarily mechlorethamine itself, pending liver function improvement.

* **Renal Impairment:**  The manufacturer's labeling doesn't specify dosage adjustments for kidney problems.

* **Obesity:**  The American Society of Clinical Oncology (ASCO) guidelines recommend using the patient's actual body weight for dosage calculations, especially in curative-intent treatment, and carefully managing toxicities as in non-obese patients.


### Side Effects

Mechlorethamine can cause a wide range of side effects, varying in severity and frequency.  These include:

* **Common:** Nausea, vomiting, diarrhea, mucositis (mouth sores), headache, fatigue, and rash.
* **Less Common but Serious:** Bone marrow suppression (leading to low blood counts – leukopenia, thrombocytopenia, anemia),  increased risk of infection,  bleeding,  hair loss (alopecia),  organ damage, hypersensitivity reactions (including anaphylaxis), and secondary cancers.

**Note:** This is not an exhaustive list.  If you experience any adverse effects, contact your healthcare provider immediately.


### How it Works

Mechlorethamine is an alkylating agent.  It works by binding to DNA, preventing its replication and causing cell death, particularly in rapidly dividing cancer cells.  It's not specific to any one phase of the cell cycle but is most effective during the S-phase (DNA synthesis).


### Precautions

* **Contraindications:**  Mechlorethamine is contraindicated in patients with known hypersensitivity (allergy) to the drug or its components and those with active infections.

* **Warnings:**  Extravasation (leakage of the drug from the vein during IV administration) can cause severe tissue damage.  The drug is highly toxic and requires careful handling by trained healthcare professionals to minimize exposure risks.  Special precautions are needed to prevent inhalation, skin contact, and eye exposure.

* **Drug Interactions:**  Mechlorethamine can interact with several other drugs, potentially reducing the effectiveness of some (like BCG) or increasing the risk of side effects from others (like other antineoplastic agents). It's crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking.

* **Pregnancy and Lactation:**  Mechlorethamine is categorized as Pregnancy Category D, meaning it poses a significant risk to the developing fetus. It's contraindicated during pregnancy and breastfeeding.

* **Specific Populations:**  Patients with pre-existing bone marrow suppression, anemia, thrombocytopenia, or compromised immune systems require close monitoring. Older adults may be more susceptible to side effects.


### FAQs

* **Q: How is mechlorethamine stored?** A:  Mechlorethamine requires specific storage conditions as outlined by the manufacturer and your healthcare provider. Usually, this involves refrigeration and protection from light.

* **Q: How long does it take to work?** A:  The effects of mechlorethamine are not immediate.  Therapeutic benefits might take several weeks or even months to become apparent.

* **Q: What should I do if I miss a dose?** A: Never adjust your dosage without consulting your doctor. They will guide you on the best course of action.

* **Q: Is mechlorethamine safe?** A:  Mechlorethamine is a potent cytotoxic drug with significant risks.  It should only be used under the close supervision of an oncologist experienced in managing its side effects and interactions.  The benefits must outweigh the significant risks.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here is based on generally available information and may not reflect all specific formulations or updated guidelines.
